A detailed history of Roberts Glore & CO Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Roberts Glore & CO Inc holds 15,224 shares of DGX stock, worth $2.09 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
15,224
Previous 15,519 1.9%
Holding current value
$2.09 Million
Previous $2.14 Million 5.28%
% of portfolio
0.61%
Previous 0.67%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$123.78 - $142.11 $36,515 - $41,922
-295 Reduced 1.9%
15,224 $2.03 Million
Q4 2023

Feb 12, 2024

SELL
$120.62 - $141.12 $2,412 - $2,822
-20 Reduced 0.13%
15,519 $2.14 Million
Q2 2023

Aug 14, 2023

SELL
$130.56 - $146.84 $30,420 - $34,213
-233 Reduced 1.48%
15,539 $2.18 Million
Q1 2023

May 08, 2023

SELL
$131.53 - $155.76 $20,387 - $24,142
-155 Reduced 0.97%
15,772 $2.23 Million
Q4 2022

Feb 13, 2023

SELL
$123.31 - $157.26 $214,559 - $273,632
-1,740 Reduced 9.85%
15,927 $2.49 Million
Q3 2022

Nov 07, 2022

SELL
$121.77 - $141.1 $8,523 - $9,877
-70 Reduced 0.39%
17,667 $2.17 Million
Q2 2022

Aug 11, 2022

SELL
$127.07 - $145.39 $13,342 - $15,265
-105 Reduced 0.59%
17,737 $2.36 Million
Q1 2022

May 02, 2022

SELL
$129.09 - $164.35 $2,710 - $3,451
-21 Reduced 0.12%
17,842 $2.44 Million
Q4 2021

Feb 11, 2022

BUY
$140.36 - $173.01 $18,808 - $23,183
134 Added 0.76%
17,863 $3.09 Million
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $35,098 - $41,712
-264 Reduced 1.47%
17,729 $2.58 Million
Q2 2021

Aug 10, 2021

SELL
$126.66 - $141.48 $22,165 - $24,759
-175 Reduced 0.96%
17,993 $2.38 Million
Q1 2021

May 06, 2021

SELL
$114.63 - $133.34 $27,281 - $31,734
-238 Reduced 1.29%
18,168 $2.33 Million
Q4 2020

Feb 09, 2021

SELL
$112.7 - $128.05 $6,198 - $7,042
-55 Reduced 0.3%
18,406 $2.19 Million
Q3 2020

Nov 06, 2020

BUY
$107.05 - $130.01 $35,326 - $42,903
330 Added 1.82%
18,461 $2.11 Million
Q2 2020

Aug 13, 2020

SELL
$73.34 - $122.61 $74,953 - $125,307
-1,022 Reduced 5.34%
18,131 $2.07 Million
Q1 2020

May 11, 2020

BUY
$75.14 - $115.68 $17,657 - $27,184
235 Added 1.24%
19,153 $1.54 Million
Q4 2019

Feb 13, 2020

BUY
$100.29 - $107.99 $597,728 - $643,620
5,960 Added 45.99%
18,918 $2.02 Million
Q3 2019

Nov 08, 2019

SELL
$97.85 - $107.42 $6,360 - $6,982
-65 Reduced 0.5%
12,958 $1.39 Million
Q2 2019

Aug 09, 2019

SELL
$85.18 - $101.94 $6,388 - $7,645
-75 Reduced 0.57%
13,023 $1.33 Million
Q4 2018

Feb 08, 2019

SELL
$79.75 - $108.38 $67,787 - $92,123
-850 Reduced 6.09%
13,098 $1.09 Million
Q3 2018

Nov 09, 2018

BUY
$105.42 - $114.99 $23,719 - $25,872
225 Added 1.64%
13,948 $1.51 Million
Q2 2018

Aug 10, 2018

SELL
$97.35 - $113.14 $28,718 - $33,376
-295 Reduced 2.1%
13,723 $1.51 Million
Q1 2018

May 08, 2018

SELL
$96.42 - $107.88 $10,124 - $11,327
-105 Reduced 0.74%
14,018 $1.41 Million
Q4 2017

Feb 09, 2018

SELL
$90.86 - $100.24 $37,706 - $41,599
-415 Reduced 2.85%
14,123 $1.39 Million
Q3 2017

Nov 08, 2017

BUY
$91.96 - $108.35 $14,713 - $17,336
160 Added 1.11%
14,538 $1.36 Million
Q2 2017

Aug 15, 2017

BUY
N/A
14,378
14,378 $1.6 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.